Clinical Trials Directory

Trials / Completed

CompletedNCT01348321

Comparison of Efficacy of Azithromycin and Levamisole Versus of Azithromycin in in the Treatment of Acne

Superior Efficacy of Azithromycin and Levamisole Versus of Azithromycin Alone in the Treatment of Inflammatory Acne Vulgaris: An Investigator Blind Randomized Clinical Trial on 169 Patients

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
169 (actual)
Sponsor
Ahvaz Jundishapur University of Medical Sciences · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Different immunologic mechanisms contribute to development of inflammation in acne vulgaris and immunologic effect of levamisole has been demonstrated. Objective: The aim of this study was to compare azithromycin and levamisole with azithromycin alone in the treatment of acne vulgaris.

Detailed description

An investigator blind clinical randomized prospective two months study was designed. One hundred sixty nine acne patients presenting in our outpatients clinic were randomly allocated to two treatment groups: azithromycin and levamisole ( group 1 ) and azithromycin alone ( group 2 ) .One hundred forty eight patients completed the duration of the study and their clinical responses were evaluated and compared by using monthly photographic records .

Conditions

Interventions

TypeNameDescription
DRUGLevamisoleGroup 1: Azithromycin 500 mg per day, three days a week plus oral levamisole 150 mg per day, two days a week. Group 2: Azithromycin 500 mg per day, three days a week. The used medications were not revealed to their physician. A questionnaire was filled for every patient and photos were taken from lesions using a digital camera at first, second and final visit.

Timeline

Start date
2008-11-01
Primary completion
2009-10-01
Completion
2009-10-01
First posted
2011-05-05
Last updated
2011-05-05

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01348321. Inclusion in this directory is not an endorsement.